학술논문

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial
Document Type
Journal
Source
FRONTIERS IN PHARMACOLOGY; DEC 21 2023, 14 p1296188 13p.
Subject
Language
English
ISSN
16639812